News

Roche Is Building a Global Digital Hub in Hyderabad — A Commitment to India's Tech Ecosystem at the Highest Institutional Level

By Mustafa Shariff, Editor in Chief · Aug 03,2026 · 2 min read

Summary

• Roche Opens Global Digital Hub in Hyderabad: Data Science, AI, and Digital Health Platform Development for Global Operations
• Roche is establishing a global digital hub in Hyderabad, India — set to become operational in Q1 2027 — to support digital innovation, data science, AI, and software engineering across its global healthcare and life sciences operations.

"India has established itself as a world-class technology hub. By establishing our global digital hub in Hyderabad, we are deepening our commitment to the Indian technology ecosystem and enabling our teams globally to leverage the exceptional talent and innovation capabilities here. This hub will support digital innovation across our healthcare and life sciences operations worldwide — from data science and AI to software engineering and digital health platform development."

Roche, the Basel-headquartered global pharmaceutical and in vitro diagnostics company, is establishing a new global technology hub in Hyderabad, India — set to become operational in the first quarter of 2027. The hub will strengthen Roche's global technology network and support digital innovation across its healthcare and life sciences operations worldwide, covering data science, artificial intelligence, software engineering, and digital health platform development.

The Roche Hyderabad Digital Hub is the latest in a growing series of major global pharmaceutical and healthcare technology companies building significant India-based engineering and data science centres. AstraZeneca has its global AI Centre in Bengaluru. Novartis operates significant NIBR (Novartis Institutes for BioMedical Research) and Global Service Centre activities from India. Sanofi and Pfizer have both built India-based global capability centres serving their worldwide operations. Roche's Hyderabad investment follows this pattern — using India's exceptional technology talent depth to build engineering capabilities that serve global healthcare operations at scale and at quality.

Why Hyderabad for a Pharma Digital Hub
Hyderabad's selection as the location for Roche's global digital hub is strategically consistent with the city's established position as India's second major technology hub alongside Bengaluru. Hyderabad's HITEC City and the surrounding technology corridor host the India operations of Microsoft, Google, Amazon, Accenture, Deloitte, and dozens of other global technology leaders. The city's pharmaceutical manufacturing and life sciences ecosystem — anchored by Genome Valley (BHC Media covered Neuland Laboratories' $20 million process development facility there in June 18 edition and the Axis Bank-BITS Pilani research park in July 2 edition) — makes Hyderabad uniquely positioned for a pharmaceutical company's digital hub: it can draw from both the technology talent pool and the pharmaceutical science and regulatory talent that the life sciences cluster provides.

What the Hub Will Build
The Hyderabad hub's focus areas — data science, artificial intelligence, software engineering, and digital health platform development — reflect the full spectrum of Roche's digital transformation agenda. Roche has been among the most digitally ambitious of global pharmaceutical companies, with investments in data platforms for clinical trial operations, AI-driven drug discovery through its Genentech subsidiary, digital diagnostics enabling platforms, and patient-facing digital health tools.
The specific capabilities being built in Hyderabad will serve Roche's global operations in each of these domains: supporting the data infrastructure that powers Roche's clinical development pipeline, building and maintaining the software platforms that Roche's commercial and regulatory teams use globally, and developing the digital health applications that Roche is deploying across its disease area portfolio including oncology, haematology, immunology, ophthalmology, and rare disease.

The India Global Capability Centre Pattern
Roche's Hyderabad hub is part of a broader strategic pattern that India's technology policy has been deliberately fostering: global capability centres (GCCs) — formerly called global in-house centres — that serve as the India-based engineering and service delivery arms of multinational corporations. India's GCC ecosystem has approximately 1,600 centres employing approximately 1.9 million professionals, contributing an estimated $50 billion to India's services export revenue. Healthcare and pharmaceutical GCCs represent a growing subset of this ecosystem, with India's combination of engineering talent, pharmaceutical science expertise, and regulatory knowledge making it uniquely valuable for pharmaceutical companies' digital transformation agendas.

Roche's Artelus Drishti collaboration (covered in BHC Media's June 30 edition — the AI-on-a-chip offline diabetic retinopathy screening system), and now the Hyderabad Global Digital Hub, together demonstrate Roche's dual commitment to India: as a market for healthcare innovation deployment, and as a talent and capability source for global operations.
BHC Perspective
At Bengaluru Health Community, Roche's Hyderabad Digital Hub is a healthcare technology talent and career story as much as a corporate investment story. For BHC's network of technology-oriented healthcare founders and professionals — Roche's commitment to building data science, AI, and digital health platform capabilities in India validates the intersection of pharmaceutical science and technology expertise that BHC's mentors represent. For BHC founders in healthcare AI, pharmaceutical data science, or digital health platforms — Roche's Hyderabad hub is both a potential customer and a potential employer for your best engineers.

Frequently Asked Questions
Q: What is Roche building in Hyderabad?
A: A global digital hub set to become operational in Q1 2027, focusing on data science, artificial intelligence, software engineering, and digital health platform development to support Roche's global healthcare and life sciences operations worldwide.

Q: Why Hyderabad?
A: Hyderabad combines India's second largest technology talent pool (HITEC City corridor with Microsoft, Google, Amazon, Accenture) with its largest pharmaceutical manufacturing and life sciences cluster (Genome Valley), making it uniquely positioned for a pharmaceutical company's digital hub requiring both technology and life sciences expertise.

Q: What is the broader India GCC context?
A: India's Global Capability Centre ecosystem has ~1,600 centres employing ~1.9 million professionals, contributing ~$50 billion to services exports. Healthcare and pharma GCCs are a growing subset, with AstraZeneca, Novartis, Sanofi, and Pfizer all operating significant India-based global capability centres. Roche's Hyderabad hub follows this established pattern.